Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Paradigms for Resectable Disease in Annals of Surgery 2018.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

1. Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?Journal of gastrointestinal cancer · 2022
   Pooled it
2. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis.PloS one · 2019
   Pooled it
3. Liver transplantation as a new treatment option for perihilar cholangiocarcinoma and colorectal liver metastases: a review.International journal of clinical oncology · 2026
   Review
4. New Insights in the Setting of Transplant Oncology.Medicina (Kaunas, Lithuania) · 2023
   Review
5. Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study.BJS open · 2023
   Article
6. New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy.Cancers · 2023
   Review
7. Primary sclerosing cholangitis-A long night's journey into day.Clinical liver disease · 2022
   Review
8. Cholangiocarcinoma and liver transplantation: What we know so far?World journal of gastrointestinal pathophysiology · 2021
   Review
9. Liver Transplantation for Peri-hilar Cholangiocarcinoma.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2020
   Review
10. Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma.World journal of gastroenterology · 2020
    Review
11. Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology.Journal of clinical medicine · 2020
    Review
12. Selection of Hepatocellular Carcinoma Patients for Liver Transplantation: Should the Threshold for Expected Oncological Survival Be Lowered?Transplantation direct · 2019
    Article

Corrections and comments

• Comment on
  Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.2018

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as